Cargando…

Aspirin inhibits the SHH/GLI1 signaling pathway and sensitizes malignant glioma cells to temozolomide therapy

Aberrant activation of sonic hedgehog (SHH)/glioma-associated oncogene homolog 1 (GLI1) pathway plays an important role in the tumorigenicity of malignant glioma cells and resistance to temozolomide (TMZ). Here we investigated the aspirin's antineoplastic molecular route by targeting SHH/GLI1 p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ming, Jianguang, Sun, Bo, Li, Ziwei, Lin, Lin, Meng, Xiangqi, Han, Bo, Wang, Ruijia, Wu, Pengfei, Li, Jianlong, Cai, Jinquan, Jiang, Chuanlu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425124/ https://www.ncbi.nlm.nih.gov/pubmed/28446712 http://dx.doi.org/10.18632/aging.101224

Ejemplares similares

GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment
por: Li, Jianlong, et al.
Publicado: (2016)

Mutant IDH1 Enhances Temozolomide Sensitivity via Regulation of the ATM/CHK2 Pathway in Glioma
por: Lin, Lin, et al.
Publicado: (2021)

Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways
por: Meng, Xiangqi, et al.
Publicado: (2020)

DNA damage repair alterations modulate M2 polarization of microglia to remodel the tumor microenvironment via the p53-mediated MDK expression in glioma
por: Meng, Xiangqi, et al.
Publicado: (2019)

MicroRNA-326 sensitizes human glioblastoma cells to curcumin via the SHH/GLI1 signaling pathway
por: Yin, Shi, et al.
Publicado: (2018)

Lnc-TALC promotes O(6)-methylguanine-DNA methyltransferase expression via regulating the c-Met pathway by competitively binding with miR-20b-3p
por: Wu, Pengfei, et al.
Publicado: (2019)

ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma
por: Han, Bo, et al.
Publicado: (2020)

Roles of Long Noncoding RNAs in Conferring Glioma Progression and Treatment
por: Qin, Jie, et al.
Publicado: (2021)

Epigenetic silencing of miR-338 facilitates glioblastoma progression by de-repressing the pyruvate kinase M2-β-catenin axis
por: Han, Bo, et al.
Publicado: (2017)

Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010)

CAFs-derived SCUBE1 promotes malignancy and stemness through the Shh/Gli1 pathway in hepatocellular carcinoma
por: Zhao, Jungang, et al.
Publicado: (2022)

Comparative Analysis of Matrix Metalloproteinase Family Members Reveals That MMP9 Predicts Survival and Response to Temozolomide in Patients with Primary Glioblastoma
por: Li, Qingbin, et al.
Publicado: (2016)

Suppressor of fused (Sufu) represses Gli1 transcription and nuclear accumulation, inhibits glioma cell proliferation, invasion and vasculogenic mimicry, improving glioma chemo-sensitivity and prognosis
por: Liu, Xing, et al.
Publicado: (2014)

HK3 stimulates immune cell infiltration to promote glioma deterioration
por: Li, Shupeng, et al.
Publicado: (2023)

Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide
por: Kanzawa, T, et al.
Publicado: (2003)

Spatiotemporal Expression of SHH/GLI Signaling in Human Fetal Bladder Development
por: Zhang, Haibao, et al.
Publicado: (2021)

Gli2-Mediated Shh Signaling Is Required for Thalamocortical Projection Guidance
por: Callejas-Marin, Antuca, et al.
Publicado: (2022)

KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment
por: D'Alessandro, Giuseppina, et al.
Publicado: (2016)

NoncoRNA: a database of experimentally supported non-coding RNAs and drug targets in cancer
por: Li, Lulu, et al.
Publicado: (2020)

Temozolomide Chemotherapy in Patients with Recurrent Malignant Gliomas
por: Yang, Seung-Ho, et al.
Publicado: (2006)

The strategy for enhancing temozolomide against malignant glioma
por: Nakada, Mitsutoshi, et al.
Publicado: (2012)

Ptch1 and Gli regulate Shh signalling dynamics via multiple mechanisms
por: Cohen, Michael, et al.
Publicado: (2015)

Immunohistochemical analysis of SHH, SMO and GLI-1 proteins in epithelial odontogenic lesions
por: Rodrigues, Katianne Soares, et al.
Publicado: (2022)

Efficacy and Safety of Temozolomide Combined with Radiotherapy in the Treatment of Malignant Glioma
por: Wei, Shoufeng, et al.
Publicado: (2022)

Targeting autophagy to sensitive glioma to temozolomide treatment
por: Yan, Yuanliang, et al.
Publicado: (2016)

Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas
por: Cai, Jinquan, et al.
Publicado: (2016)

Treating malignant glioma in Chinese patients: update on temozolomide
por: Chang, Liang, et al.
Publicado: (2014)

IMMU-28. IMMUNOGENOMIC ANALYSIS REVEALS LGALS1 CONTRIBUTES TO THE IMMUNE HETEROGENEITY AND IMMUNOSUPPRESSION IN GLIOMA
por: Chen, Qun, et al.
Publicado: (2020)

A Voxel-Based Radiographic Analysis Reveals the Biological Character of Proneural-Mesenchymal Transition in Glioblastoma
por: Qi, Tengfei, et al.
Publicado: (2021)

Inhibitory Effects of Rhein on Renal Interstitial Fibrosis via the SHH-Gli1 Signal Pathway
por: Luo, Yan, et al.
Publicado: (2022)

Yeast-based assay identifies novel Shh/Gli target genes in vertebrate development
por: Milla, Luis A, et al.
Publicado: (2012)

MBRS-06. Gli3 INDUCES NEURONAL DIFFERENTIATION IN WNT- AND SHH- ACTIVATED MEDULLOBLASTOMA
por: Natsumeda, Manabu, et al.
Publicado: (2020)

Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy
por: Jiang, Pengfei, et al.
Publicado: (2016)

Gli3 in fetal thymic epithelial cells promotes thymocyte positive selection and differentiation by repression of Shh
por: Solanki, Anisha, et al.
Publicado: (2018)

Impact of Temozolomide on Immune Response during Malignant Glioma Chemotherapy
por: Sengupta, Sadhak, et al.
Publicado: (2012)

β-elemene combined with temozolomide in treatment of brain glioma
por: Zhang, Xiaomin, et al.
Publicado: (2021)

Influence of SHH/GLI1 axis on EMT mediated migration and invasion of breast cancer cells
por: Riaz, Syeda Kiran, et al.
Publicado: (2019)

Inhibition of mitochondrial carrier homolog 2 (MTCH2) suppresses tumor invasion and enhances sensitivity to temozolomide in malignant glioma
por: Yuan, Qiuyun, et al.
Publicado: (2021)

Radiation combined with temozolomide contraindicated for young adults diagnosed with anaplastic glioma
por: Yang, Pei, et al.
Publicado: (2016)

Dexamethasone and compliance affect TTFields efficacy to glioblastoma patients: a systematic review and meta-analysis
por: Li, Shupeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1nvn5hf000u7h72cscq9l6qj6g